UVB photoprotective capacity of hydrogels containing dihydromyricetin nanocapsules to UV-induced DNA damage

We evaluate the effect of cationic nanocapsules containing dihydromyricetin (DMY) flavonoid for safe topical use in photoprotection against UV-induced DNA damage. The stability was investigated for feasibility to produce hydrogels containing cationic nanocapsules of the flavonoid DMY (NC-DMY) for 90 days under three different storage conditions (4 +/- 2 degrees C, 25 +/- 2 degrees C, and 40 +/- 2 degrees C), as well as evaluation of skin permeation and its cytotoxicity in skin cell lines. The physicochemical and rheological characteristics were maintained during the analysis period under the different aforementioned conditions. However, at 25 degrees C and 40 degrees C, the formulations indicated yellowish coloration and DMY content reduction. Therefore, the ideal storage condition of 4 degrees C was adopted. DMY remained in the stratum corneum and the uppermost layers of the skin. Regarding safety, all formulations demonstrated to be safe for topical application. NC-DMY exhibited a 50% Solar Protection Factor (SPF-DNA) against DNA damage caused by UVB radiation and demonstrated 99.9% protection against DNA lesion induction. These findings establish a promising formulation containing nanoencapsulated DMY flavonoids with a photoprotective and antioxidant potential of eliminating reactive oxygen species formed by solar radiation.

Automated summary

The study found that cationic nanocapsules containing DMY flavonoids can be safely used topically to protect the skin from UV-induced DNA damage. The formulation remained stable at 4 degrees Celsius, demonstrated skin safety, and provided significant photoprotection and antioxidant potential.